Halozyme Therapeutics, Inc. (HALO)
62.64
+0.77
(+1.24%)
USD |
NASDAQ |
Dec 10, 16:00
62.73
+0.09
(+0.14%)
After-Hours: 18:20
Halozyme Therapeutics Market Cap: 7.366B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 242.20B |
| ANI Pharmaceuticals, Inc. | 1.842B |
| Bristol Myers Squibb Co. | 104.24B |
| Twist Bioscience Corp. | 2.004B |
| Aurinia Pharmaceuticals, Inc. | 2.042B |
Market Cap Related Metrics
| PE Ratio | 13.17 |
| PS Ratio | 6.327 |
| PEG Ratio | 0.2293 |
| Price to Book Value | 14.62 |
| Price to Free Cash Flow | 13.05 |
| Price | 62.64 |
| Earnings Yield | 7.59% |
| PEGY Ratio | 0.2293 |
| Operating PE Ratio | 10.66 |
| Normalized PE Ratio | 13.17 |